InVivo Therapeutics (NSDQ:NVIV) said today that a patient enrolled in January in its Inspire study has improved from a complete AIS A spinal cord injury to an incomplete AIS B spinal cord injury. This is the 7th patient from the 11-patient group to have an AIS grade improvement with at least 1-month of follow-up. 2 other […]
Orthopedics
Welcome to MassDevice's Orthopedics Hub, your resource for the latest in orthopedic news. Stay informed about the innovations and business news shaping the ortho device industry.
🦴 Narrow your focus with these categories:
Implants | Metal-on-Metal | Spine
Here are the top orthopedic device features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ The biggest stories from AAOS 2024
+ The 10 largest orthopedic device companies in the world
+ The ZimVie Tether helps kids with scoliosis — if they can get it in time
+ Could 2023 be a boom year for orthopedic devices?
+ The top orthopedic device news out of AAOS 2023
🎙️ Tune in to the Ortho Innovation Talks podcast on the DeviceTalks podcast network.
Latest Orthopedics News
Alphatec raises $19m in private placement
Alphatec (NSDQ:ATEC) said it inked a deal to raise roughly $18.9 million in a private placement led by “new healthcare-dedicated institutional investors.” The placement, expected to close March 28, also included Alphatec directors and executives and other existing backers, the company said. The proceeds are earmarked for general corporate and working capital expenses, Alphatec said. “We appreciate the […]
7 medtech stories we missed this week: March 24, 2017
From companies receiving CE marking to other companies adjusting their distribution deals, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. Viveve Medical closes public offering Viveve Medical announced that it closed its underwritten public offering of 8,625,00 shares of its common stock, according to a March 22 […]
InVivo wins Health Canada nod for cervical neuro-spinal scaffold trial
InVivo Therapeutics (NSDQ:NVIV) said today it won Health Canada approval to initiate a clinical study of its neuro-spinal scaffold in patients with acute, complete AIS A cervical spinal cord injuries. The Cambridge, Mass.-based company said it is in late stage conversations with several site research ethics boards, and expects to announce the 1st Canadian site for the […]
Progenitor cell therapy improves motor function in patients with spinal cord injury
Shares in Asterias Biotherapeutics (NYSE:AST) jumped 11% today to $3.53 apiece after the company reported positive data for its AST-OPC1 progenitor cell therapy in patients with spinal cord injuries. The Phase 1/2A clinical trial includes 6 patients in the AIS-A 10 million cell cohort. The company’s AST-OPC1 progenitor cell therapy is derived from human embryonic […]
NuVasive wins UK NICE support for XLIF procedure
NuVasive Inc. (NSDQ:NUVA) said today that the U.K.’s National Industry for Clinical Excellence issued updated guidance which supports the use of lateral interbody fusion in the lumbar spine, including its eXtreme Lateral Interbody Fusion procedure. The San Diego-based company touted that the majority of the evidence submitted to NICE to support the guidance change came from […]
InVivo submits 1st HDE module for neuro-spinal scaffold
InVivo Therapeutics (NSDQ:NVIV) said today it submitted its 1st nonclinical study module to the FDA as part of its humanitarian device exemption submission for its neuro-spinal scaffold. The neuro-spinal scaffold is designed to be surgically implanted following acute spinal cord injuries to act as a physical substrate for nerve sprouting, the Cambridge, Mass.-based company said. The submission […]
InVivo Therapeutics enrolls 13th patient in neuro-spinal scaffold trial
InVivo Therapeutics (NSDQ:NVIV) said today that it enrolled a new patient in the Inspire study of its neuro-spinal scaffold, bringing the total number treated up to 13. The Cambridge, Mass.-based company’s neuro-spinal scaffold is designed to be surgically implanted following acute spinal cord injuries to act as a physical substrate for nerve sprouting. The procedure was […]
Failure to thrive: Lessons learned from medtech innovations that missed the mark
Some of the medical device industry’s most heralded disruptors wound up being its biggest failures. Here’s what we can learn from their mistakes. Fink Densford, Associate Editor No one in medtech sets out to fail. No one invests in building a device believing that, despite years of research and development, it won’t make the cut. […]
Moximed closes $50m Series C
California orthopedic device developer Moximed said today it raised $50 million in a Series C round of financing. The round was joined by newly invested Advent Life Sciences and Future fund and existing investors NEA, Morgenthaler Ventures, Gilde Healthcare, GBS Venture Partners and Vertex Healthcare. “This financing round is timely, as we are completing the primary […]
Zimmer Biomet shoots for robot-assisted total knee release next year
Zimmer Biomet (NYSE:ZBH) expects to launch a robot-assisted surgery platform for total knee procedures during the 2nd half of 2018, the company said this week at the annual conference of the American Academy of Orthopedic Surgeons in San Diego. A prototype of the device, on display at the AOSS conference, is based on the Rosa technology Zimmer Biomet […]